Cargando…
Association between ranitidine use with potential NDMA impurities and risk of cancer in Korea
N-Nitrosodimethylamine (NDMA) detected above the acceptable level in ranitidine products has been a great global concern. To examine the risk of cancer among people treated with ranitidine, we conducted a cohort study using the National Health Insurance Service-National Sample Cohort data (2002–2015...
Autores principales: | Joung, Kyung-In, Hwang, Jung Eun, Oh, In-Sun, Cho, Sung-il, Shin, Ju-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794704/ https://www.ncbi.nlm.nih.gov/pubmed/36575247 http://dx.doi.org/10.1038/s41598-022-26691-0 |
Ejemplares similares
-
Is this the end for ranitidine? NDMA presence continues to confound
por: Wagner, Jennifer A., et al.
Publicado: (2021) -
N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings
por: Aldawsari, Fahad S., et al.
Publicado: (2021) -
In Vitro Analysis of N-Nitrosodimethylamine (NDMA) Formation From Ranitidine Under Simulated Gastrointestinal Conditions
por: Gao, Zongming, et al.
Publicado: (2021) -
Risk of Cancer Following the Use of N-Nitrosodimethylamine (NDMA) Contaminated Ranitidine Products: A Nationwide Cohort Study in South Korea
por: Yoon, Hong Jin, et al.
Publicado: (2021) -
Formation
Mechanism of NDMA from Ranitidine, Trimethylamine,
and Other Tertiary Amines during Chloramination: A Computational Study
por: Liu, Yong Dong, et al.
Publicado: (2014)